MiR‐503 is a pleiotropic regulator of lung cancer metastasis, governing both epithelial‐mesenchymal transition (EMT) and EMT‐independent PTK7/FAK signaling.MiR‐503 may represent an attractive target for therapeutic interventions in lung cancer. This evidence concerns the gene PTK2 and lung carcinoma.